28.41 (0.42%)
As of Mar 06, 2024
Source:
We are a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. We focus on diseases for which the unmet medical need is high and the biology for treatment is clear. Our pipeline consists of two clinical-stage product candidates with mechanisms of action that have potential utility across a wide range of orphan cholestatic liver diseases. Cholestasis is characterized by impaired flow of bile resulting in accumulation of toxic bile acids both in the liver and systemically.
Country | United States |
Headquarters | foster city, california |
Phone Number | 650-667-4085 |
Industry | manufacturing |
CEO | Christopher Peetz |
Website | www.mirumpharma.com |